- 010-8646- 3560
- info@wolcavi.com
NIBSC | 国际标准品
你在这里
NIBSC | 国际标准品
成立于2004 年，主要负责开发 和生产超过90%的国际标准药品，该 机构在WHO中具有较高地位。
NIBSC ，IRMM/ERM 欧洲标准品 部分现货请详询
产品订购电话：010-59446861
可以联系我们：在线QQ
或邮件：info@wolcavi.com
| Product Number | Description |
|---|---|
| 00/410 | MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation) International Reference Preparation |
| 00/416 | Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) International Reference Preparation |
| 00/418 | MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard) WHO International Standard |
| 00/422 | High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) International Reference Preparation |
| 00/440 | Influenza Antiserum A/Singapore/1/57 (H2) Influenza Reagent |
| 00/442 | Influenza anti B/Yamanashi/166/98 Serum Influenza Reagent |
| 00/464 | Streptokinase (3rd International Standard 2001) WHO International Standard |
| 00/500 | Botulinum Type A-E Antitoxin, Human Serum Non WHO Reference Material |
| 00/530 | Influenza Virus infectious B/Sichuan/379/99 Influenza Reagent |
| 00/542 | Influenza anti- A/Chick/Scotland/59 (H5N1) Serum Influenza Reagent |
| 00/544 | Influenza Virus infectious B/Victoria/504/00 Influenza Reagent |
| 00/546 | Influenza Antigen B/Johannesburg/5/99 Influenza Reagent |
| 00/552 | Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3) Influenza Reagent |
| 00/556 | Influenza anti-B/Johannesburg/5/99/ Serum Influenza Reagent |
| 00/562 | Hepatitis A Virus for Nucleic Acid Amplification Techniques(2nd International Standard) WHO International Standard |
| 00/572 | Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard) WHO International Standard |
| 00/574 | Interferon Beta SER17 Mutein (Human, rDNA derived) Non WHO Reference Material |
| 00/576 | Interferon Beta (Human, Fibroblast-derived, Glycosylated) Non WHO Reference Material |
| 00/614 | Influenza virus infectious B/Guangdong/120/2000 Influenza Reagent |
| 007SP | Human Anti-Pneumococcal capsule Reference Serum (1st International Standard) WHO International Standard |
| 01/412 | Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody Non WHO Reference Material |
| 01/420 | Interleukin-17 (Human rDNA derived)(International Reference Reagent) International Reference Reagent |
| 01/424 | Vascular Endothelial Growth Factor, Human rDNA derived Non WHO Reference Material |
| 01/426 | Meningococcal group Y polysaccharide Non WHO Reference Material |
| 01/428 | Meningococcal serogroup W polysaccharide Non WHO Reference Material |
| 01/450 | Influenza anti B/Guangdong/120/2000 Serum Influenza Reagent |
| 01/452 | Influenza anti A/Panama/2007/99 (H3N2) HA serum Influenza Reagent |
| 01/506 | Botulinum type F antitoxin, equine Non WHO Reference Material |
| 01/508 | Botulinum type C antitoxin, equine Non WHO Reference Material |
| 01/510 | Botulinum Antitoxin Equine Type D Non WHO Reference Material |
| 01/512 | Botulinum type G antitoxin, equine Non WHO Reference Material |
| 01/514 | Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody Non WHO Reference Material |
| 01/538 | Anti-Meningococcal Serosubtype P1.16 mAb Non WHO Reference Material |
| 01/546 | Influenza Antigen B/Guangdong/120/2000 Influenza Reagent |
| 01/572 | Anti-D Immunoglobulin(2nd International Standard) WHO International Standard |
| 01/580 | Thrombin, human(2nd International Standard) WHO International Standard |
| 01/600 | Anti-Toxoplasma IgG, Human(International Standard) WHO International Standard |
| 01/602 | Anti-Parvovirus B19, plasma, human(2nd International Standard) WHO International Standard |
| 01/612 | Influenza Virus infectious B/Hawaii/10/01 Influenza Reagent |
| 01/614 | Influenza Antigen A/New Caledonia/20/99 Influenza Reagent |
| 02/102 | Influenza anti A/Panama/2007/99 Serum Influenza Reagent |
| 02/144 | Anti-Meningococcal Serosubtype P1.15 mAb Non WHO Reference Material |
| 02/148 | Anti-Meningococcal Serosubtype P1.4 mAb Non WHO Reference Material |
| 02/168 | Prekallikrein Activator (PKA), Human(2nd International Standard) WHO International Standard |
| 02/178 | Anti-Meningococcal Serosubtype P1.2 mAb Non WHO Reference Material |
| 02/180 | Anti-Meningococcal Serotype P2.2a mAb Non WHO Reference Material |
| 02/182 | Anti-Japanese Encephalitis Virus Plasma, Human Non WHO Reference Material |
| 02/184 | Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human Non WHO Reference Material |
| 02/206 | Factor XIII Plasma, Human (1st International Standard) WHO International Standard |
| 02/210 | HIV (antibody), 1st International Reference Panel International Reference Preparation |
| 02/226 | IVIG negative control for use with IVIG + anti-D(International Reference Reagent) International Reference Reagent |
| 02/228 | IVIG + anti-D for use with negative control IVIG(International Reference Reagent) International Reference Reagent |
| 02/230 | Biotinylated Brad-5 (Bio-Brad-5) Working Standard |
| 02/232 | Tetanus Toxoid (Non-Adsorbed) Non WHO Reference Material |
| 02/254 | Insulin-like Growth Factor-1, recombinant, human, for immunoassay(1st International Standard) WHO International Standard |
| 02/262 | Influenza Virus infectious B/Brisbane/32/2002 Influenza Reagent |
| 02/286 | Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent) International Reference Reagent |
| 02/294 | Influenza Antiserum A/chick/Italy/1347/99 (H7N1) Influenza Reagent |
| 02/308 | Anti-Meningococcal Serotype P3.4 mAb Non WHO Reference Material |
| 02/310 | Anti-Meningococcal Serotype P3.15 mAb Non WHO Reference Material |
| 02/318 | Botulinum Antitoxin Equine Type E Non WHO Reference Material |
| 02/320 | Anti-Meningococcal Serosubtype P1.3 mAb Non WHO Reference Material |
| 02/336 | Influenza Antigen A/New Caledonia/20/99 Influenza Reagent |
| 02/338 | Influenza anti A/Panama/2007/99 Serum Influenza Reagent |
| 02/342 | Protein C Plasma, Human(2nd International Standard) WHO International Standard |
| 03/104-017 | HTLV-1 (antibody) Monitor Sample CE Marked Material |
| 03/110 | Influenza anti B/Shangdong/9/97 Serum Influenza Reagent |
| 03/114 | Anti-Meningococcal Serosubtype P1.1 mAb Non WHO Reference Material |
| 03/116 | Blood Coagulation Factor V, Plasma Human (1st International Standard) WHO International Standard |
| 03/124 | Thrombopoietin ( Human rDNA derived) Non WHO Reference Material |
| 03/142 | Anti-Meningococcal Serosubtype P1.14 mAb Non WHO Reference Material |
| 03/148 | Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent) International Reference Reagent |
| 03/150 | Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent) International Reference Reagent |
| 03/152 | Anti-HPA-1a (International Standard) WHO International Standard |
| 03/164 | Anti-B minimum potency reference preparation(International Standard) WHO International Standard |
| 03/178 | Vitamin B12, Serum Folate and holoTC (International standard) WHO International Standard |
| 03/182 | Anti-Meningococcal Serotype P3.21 mAb Non WHO Reference Material |
| 03/188 | Anti-A minimum potency reference preparation(International Standard) WHO International Standard |
| 03/190 | Anti-HPA-3a(minimum potency)(International Reference Reagent) International Reference Reagent |
| 03/192 | Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard) WHO International Standard |
| 03/198 | Influenza Virus infectious A/Kumamoto/102/02 Influenza Reagent |
| 03/200 | Interleukin - 18 (Human rDNA derived)(International Reference Reagent) International Reference Reagent |
| 03/210 | Anti-Meningiococcal Serosubtype P1.6 mAb Non WHO Reference Material |
| 03/212 | Influenza anti A/Wyoming/03/03 Serum Influenza Reagent |
| 03/220 | Influenza Antigen A/Wyoming/03/03 Influenza Reagent |
| 03/224 | Anti-Meningococcal Serosubtype P1.10 mAb Non WHO Reference Material |
| 03/226 | Anti-Meningococcal Serosubtype P1.5 mAb Non WHO Reference Material |
| 03/228 | Protein S, Plasma, Human(2nd International Standard) WHO International Standard |
| 03/236 | Anti-Meningococcal Serosubtype P1.13 mAb Non WHO Reference Material |
| 03/242 | Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum Influenza Reagent |
| 03/244 | Influenza Antiserum A/chick/Germany/N/49 Influenza Reagent |
| 03/258 | Influenza Antigen A/New Caledonia/20/99 (IVR-116) Influenza Reagent |
| 03/262 | Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel) International Reference Preparation |
| 04/122 | Anti-Meningococcal Serosubtype P1.12 mAb Non WHO Reference Material |
| 04/132 | IVIG + Anti-D for use with negative control IVIG Non WHO Reference Material |
| 04/140 | IVIG Negative Control for use with IVIG & Anti-D Non WHO Reference Material |
| 04/150 | Tetanus Toxoid For Flocculation Test(2nd International Standard) WHO International Standard |
| 04/160 | Influenza Virus infectious NYMC X-147 Influenza Reagent |
| 04/166 | TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent) WHO International Standard |
| 04/170 | Influenza Virus infectious A/Wellington/1/2004 Influenza Reagent |
| 04/172 | Influenza Virus infectious IVR-139 Influenza Reagent |
| 04/176 | Plasmodium falciparum DNA for NAT Assays(1st International Standard) WHO International Standard |
| 04/198 | Anti-Meningococcal Serotype P3.1 mAb Non WHO Reference Material |
| 04/200 | Parathyroid hormone 1-34 ,Recombinant, Human(International Standard) WHO International Standard |
| 04/202 | Influenza Antigen B/ Jiangsu/10/2003 Influenza Reagent |
| 04/214 | Influenza anti A/Vietnam/1194/04 (NIBRG-14) HA Serum (sheep SH440&SH442) Influenza Reagent |
| 04/224 | Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004 WHO International Standard |
| 04/228 | Influenza anti B/ Neuraminidase Serum Influenza Reagent |
| 04/242 | Influenza anti B/Jiangsu/10/2003 HA Serum Influenza Reagent |
| 04/246 | Anti-Meningococcal Serogroup W-135 mAb Non WHO Reference Material |
| 04/248 | Anti-Meningococcal Serosubtype P1.19 mAb Non WHO Reference Material |
| 04/252 | Protein C Concentrate, Human(1st International Standard) WHO International Standard |
| 04/260 | Influenza anti A/New Caledonia/20/99 HA Serum Influenza Reagent |
| 04/262 | Influenza anti A/New York/55/2004 HA Serum Influenza Reagent |
| 04/264 | Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157) Influenza Reagent |
| 05/102 | Influenza Virus infectious NYMC BX-7 Influenza Reagent |
| 05/106 | Anti-HPA-1a minimum potency reagent(2nd International Reference reagent) International Reference Reagent |
| 05/110 | Influenza Virus infectious A/California/7/2004 Influenza Reagent |
| 05/112 | Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard). WHO International Standard |
| 05/122 | Syphilitic plasma IgG (human)(1st International Standard) WHO International Standard |
| 05/130 | Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005) WHO International Standard |
| 05/132 | Syphilitic plasma IgG and IgM (human)(1st International Standard) WHO International Standard |
| 05/134 | Anti-human papillomavirus type 16 serum (1st International Standard) WHO International Standard |
| 05/138 | Influenza Virus infectious B/Shanghai/361/2002 Influenza Reagent |
| 05/162 | Alpha-1-Antitrypsin, plasma derived(1st International standard) WHO International Standard |
| 05/190 | Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody Non WHO Reference Material |
| 05/192 | Anti Meningococcal Serotype P2.2b Monoclonal Antibody Non WHO Reference Material |
| 05/234 | Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142) Influenza Reagent |
| 05/236 | Influenza anti A/Wisconsin/67/2005 Serum Influenza Reagent |
| 05/242 | IVIG, Anti-D and Negative Control Panel Non WHO Reference Material |
| 05/252 | Influenza anti B Neuraminidase Serum Influenza Reagent |
| 06/108 | Influenza Virus infectious IVR-116 Influenza Reagent |
| 06/114 | Influenza Virus Infectious A/PR/8/34 Influenza Reagent |
| 06/124 | Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard) WHO International Standard |
| 06/128 | Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard) WHO International Standard |
| 06/140 | Pertussis Antiserum(human)1st IS-WHO international Standard. WHO International Standard |
| 06/142 | Pertussis Antiserum (Human) 1st WHO Reference Reagent International Reference Reagent |
| 06/164 | Influenza Virus infectious 1 VR-142 Influenza Reagent |
| 06/166 | Antithrombin Concentrate, Human (3rd International Standard) WHO International Standard |
| 06/170 | Influenza Antigen A/New Caledonia/20/99 Influenza Reagent |
| 06/192 | Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466) Influenza Reagent |
| 06/202 | Human Papillomavirus (HPV) Type 16 DNA (1st International Standard) WHO International Standard |
| 06/206 | Human Papillomavirus (HPV) Type 18 DNA (1st International Standard) WHO International Standard |
| 06/242 | Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR) Influenza Reagent |
| 07/102 | Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145) Influenza Reagent |
| 07/104 | Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum Influenza Reagent |
| 07/112 | Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 Influenza Reagent |
| 07/132 | Influenza Virus infectious B/Malaysia/2506/2004 Influenza Reagent |
| 07/144 | Influenza Virus infectious IVR-145, Influenza Reagent |
| 07/146 | Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep) Influenza Reagent |
| 07/148 | Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum Influenza Reagent |
| 07/150 | Human Plasma Anti-Influenza H5N1 (1st International Standard) WHO International Standard |
| 07/164 | Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard) WHO International Standard |
| 07/184 | Influenza anti B/Malaysia/2506/2004-HA Serum Influenza Reagent |
| 07/202 | Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent) International Reference Reagent |
| 07/214 | Positive Control for use in flow cytometry cross matching (FCXM) CE Marked Material |
| 07/216 | Diphtheria Toxoid (Adsorbed) (4th International Standard) WHO International Standard |
| 07/222 | RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent) International Reference Reagent |
| 07/226 | Influenza Virus Infectious A/New Caledonia/20/99 Influenza Reagent |
| 07/228 | Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard” WHO International Standard |
| 07/246 | Influenza Virus Infectious IVR-147 Influenza Reagent |
| 07/268 | Influenza Virus Infectious B/Brisbane/3/2007 Influenza Reagent |
| 07/270 | BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent) International Reference Reagent |
| 07/272 | BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent) International Reference Reagent |
| 07/274 | BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent) International Reference Reagent |
| 07/278 | Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475) Influenza Reagent |
| 07/286-014 | 0.05 IU HBsAg Monitor Sample CE Marked Material |
| 07/288-015 | Hepatitis B Surface Antigen British Working Standard 0.2 IU/ml CE Marked Material |
| 07/290 | Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6 Influenza Reagent |
| 07/294-006 | Norovirus GII for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 07/296-006 | Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 07/298-006 | Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 07/300-005 | Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 07/304 | Anti-D for assuring operator and test performance Working Standard |
| 07/306 | Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (International Reference Reagent) International Reference Reagent |
| 07/316 | Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.) WHO International Standard |
| 07/318 | Meningococcal Group C Polysaccharide Non WHO Reference Material |
| 07/326 | Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard. Working Standard |
| 07/328 | Unfractionated Heparin (6th I.S.) WHO International Standard |
| 07/336 | Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60 Influenza Reagent |
| 07/338 | Influenza anti A/Anhui/1/05 (H5)HA serum (IBCDC-RG6) (Sheep SH477) Influenza Reagent |
| 07/348 | Influenza Virus infectious NYMC X-171B Influenza Reagent |
| 07/350 | Blood Coagulation Factor VIII Concentrate (8th I.S.) WHO International Standard |
| 07/358 | Influenza Virus infectious NIB-50 Influenza Reagent |
| 07/362 | Influenza Virus infectious IVR-149 Influenza Reagent |
| 07/364 | Chorionic Gonadotrophin, (5th International Standard) WHO International Standard |
| 07/B498-17 | QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1 Quality Control Reagent |
| 08/100 | Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1) Influenza Reagent |
| 08/108 | Influenza Virus Infectious NIBRG-91 Influenza Reagent |
| 08/118-005 | Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 08/120-005 | Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 08/126 | Influenza anti A/turkey/Turkey/1/05(N1) NA Serum (NIBRG-74) (Sheep SH485) Influenza Reagent |
| 08/138 | Influenza Virus Infectious B/Florida/4/2006 Influenza Reagent |
| 08/140 | Influenza Antigen B/Florida/4/2006 Influenza Reagent |
| 08/142 | Influenza anti A/Anhui/1/05 (H5) HA serum (IBCDC-RG6) (sheep SH477) Influenza Reagent |
| 08/148 | Positive control for Luminex based anti-HLA Class II serology CE Marked Material |
| 08/150 | HIV-2 RNA(1st International Standard) WHO International Standard |
| 08/154 | Influenza Virus Infectious NIBRG-12 Influenza Reagent |
| 08/156 | Influenza Virus Infectious NIBRG-23 30060 VE3 Influenza Reagent |
| 08/158 | Fragile X Syndrome gDNA (1st International Genetic Reference Panel) WHO International Standard |
| 08/160 | Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel) WHO International Standard |
| 08/174-007 | Human Coxsackie B4 for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 08/176-005 | Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 08/178-005 | Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 08/180-005 | Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 08/184 | Influenza Antigen B/Malaysia/2506/2004 Influenza Reagent |
| 08/202 | Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1) Influenza Reagent |
| 08/204 | Thyroid Stimulating Antibody (2nd I.S.) WHO International Standard |
| 08/208 | Influenza Antigen Hong Kong/1073/99 (H9N2) Influenza Reagent |
| 08/210 | Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86) Influenza Reagent |
| 08/214 | Meningococcal Serogroup C polysaccharide (1st International Standard) WHO International Standard |
| 08/216 | Influenza Antigen A/Cambodia/RO405050/2007 (H5N1) Influenza Reagent |
| 08/218 | Tetanus Toxoid Adsorbed (4th International Standard) WHO International Standard |
| 08/228 | Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91 Influenza Reagent |
| 08/230 | Streptodornase (2nd International Standard) WHO International Standard |
| 08/246 | Influenza anti A/Brisbane/10/2007- like HA serum Influenza Reagent |
| 08/256 | C1- Inhibitor, Concentrate (1st International Standard) WHO International Standard |
| 08/258 | Antithrombin, Plasma (3rd International Standard) WHO International Standard |
| 08/262 | C1 Inhibitor (Plasma)(1st International Standard) WHO International Standard |
| 08/266 | Sex Hormone Binding Globulin.(2nd International Standard) WHO International Standard |
| 08/268 | Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107 Influenza Reagent |
| 08/278 | Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C)) Influenza Reagent |
| 08/282 | Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard) WHO International Standard |
| 08/298 | Influenza Virus Infectious B/Brisbane/33/2008 30720 E5 Influenza Reagent |
| 08/300 | Influenza Virus Infectious IVR-148 Influenza Reagent |
| 08/304 | Influenza virus infectious NYMC X-175C Influenza Reagent |
| 08/316-006 | Epstein-Barr Virus for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 08/318-006 | Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing Clinical Virology Network CVN |
| 08/320-007 | Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing Clinical Virology Network CVN |
| 08/322-005 | Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing Clinical Virology Network CVN |
| 08/324-005 | Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing Clinical Virology Network CVN |
| 08/356 | Influenza anti A/Japan/305/57 (H2) HA serum (A/Singapore/1/57-Like) (Sheep SH398) Influenza Reagent |
| 08/362 | Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109 Influenza Reagent |
| 09/100 | Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503) Influenza Reagent |
| 09/110 | Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard) WHO International Standard |
| 09/112 | Negative Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology CE Marked Material |
| 09/130 | Influenza Virus Infectious NIBRG-122 Influenza Reagent |
| 09/132-004 | Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing Clinical Virology Network CVN |
| 09/136 | Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard) WHO International Standard |
| 09/138 | Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.) WHO International Standard |
| 09/140 | Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel) WHO International Standard |
| 09/148 | Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505) Influenza Reagent |
| 09/154 | Clostridium sordellii (Gas-gangrene) Antitoxin, Equine,(1st International standard) WHO International Standard |
| 09/162 | Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard) WHO International Standard |
| 09/170 | Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody Non WHO Reference Material |
| 09/172 | Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010) WHO International Standard |
| 09/174 | Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived) Influenza Reagent |
| 09/182 | VWF Factor Concentrate (2nd International Standard) WHO International Standard |
| 09/184 | Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14 Influenza Reagent |
| 09/186 | Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard) WHO International Standard |
| 09/188 | Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard) WHO International Standard |
| 09/196 | Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived) Influenza Reagent |
| 09/222 | Human anti-Haemophilus influenzae b reference serum CE Marked Material |
| 09/234 | Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard) WHO International Standard |
| 09/236 | Influenza Virus Infectious IVR-153 Influenza Reagent |
| 09/242 | Fibrinogen Concentrate (B)(2nd International Standard) WHO International Standard |
| 09/260 | Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard) WHO International Standard |
| 09/264 | Fibrinogen Plasma (D)(3rd International Standard) WHO International Standard |
| 09/266 | GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived Non WHO Reference Material |
| 09/268 | Influenza Virus Infectious NIBRG-121xp Influenza Reagent |
| 09/272 | Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1) Non WHO Reference Material |
| 09/274 | Influenza Virus Infectious NYMC X-185 Influenza Reagent |
| 09/280 | Influenza Virus Infectious NIB-64 Influenza Reagent |
| 09/284 | Anti-Human Neutrophil Antibody 1a WHO Reference Reagent International Reference Reagent |
| 09/296 | Pro-Insulin, human (1st International Standard) WHO International Standard |
| 09/304 | Influenza Virus Infectious IVR-155 Influenza Reagent |
| 09/306 | Influenza Virus Infectious NIBRG-147 Influenza Reagent |
| 09/308 | Influenza serology antigen reagent for haemagglutination inhibition assay Pandemic H1N1 2009 (X179A) Working Standard |
| 09/310 | Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183) Influenza Reagent |
| 09/316 | Influenza Anti B Neuraminidase Serum (B/Florida/4/2006) Influenza Reagent |
| 09/B584-13 | QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1 Quality Control Reagent |
| 09/B588-08 | QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1 Quality Control Reagent |
| 10/104 | Reteplase Reference Material Non WHO Reference Material |
| 10/120 | Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum Influenza Reagent |
| 10/128 | Diphtheria Polyclonal Antibody Non WHO Reference Material |
| 10/130 | Diphtheria Monoclonal Antibody Non WHO Reference Material |
| 10/132 | Tetanus Polyclonal Antibody Non WHO Reference Material |
| 10/134 | Tetanus Monoclonal Antibody Non WHO Reference Material |
| 10/136-001 | HLA-DRB1 Genotyping Reference Panel CE Marked Material |
| 10/140 | Anti-human papillomavirus[HPV] 18 serum (1st International Standard) WHO International Standard |
| 10/142 | Negative control for Luminex based anti-HLA serology CE Marked Material |
| 10/152 | HIV-1 RNA (3rd International standard) WHO International Standard |
| 10/176 | Interleukin-29 (Interferon Lamda 1) International Reference Reagent |
| 10/178 | Endotoxin (3rd International Standard) WHO International Standard |
| 10/188 | Factor VIII Concentrate (13th British Standard). Working Standard |
| 10/198 | Anti-malaria (Plasmodium falciparum) human serum(1st International Reference Reagent) International Reference Reagent |
| 10/202 | Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard) WHO International Standard |
| 10/214 | Influenza Anti N2 Neuraminidase Serum SH395 & SH396 Influenza Reagent |
| 10/218 | Influenza Anti A/California/7/2009 (N1) NA Serum Influenza Reagent |
| 10/226 | Influenza Virus Infectious IVR-158 Influenza Reagent |
| 10/232 | Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent) International Reference Reagent |
| 10/234 | Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent) International Reference Reagent |
| 10/236 | Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent) International Reference Reagent |
| 10/238 | Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent) International Reference Reagent |
| 10/242 | Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard) WHO International Standard |
| 10/252 | Factor VII Concentrate(2nd International Standard) WHO International Standard |
| 10/258 | Influenza Antigen A/California/7/2009-like(NIB-74) Influenza Reagent |
| 10/262 | Diphtheria Antitoxin Human IgG(1st International Standard) WHO International Standard |
| 10/266 | 4th WHO International Standard for HBV DNA for NAT WHO International Standard |
| 10/272 | BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent) International Reference Reagent |
| 10/280 | Anti-HLA Control CE Marked Material |
| 10/286 | Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard) WHO International Standard |
| 10/B596-10 | QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1 Quality Control Reagent |
| 1050 | IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050) Non WHO Reference Material |
| 11/106 | Influenza Virus infectious A/Perth/16/2009 Influenza Reagent |
| 11/108 | Influenza Virus infectious NYMC X-187 Influenza Reagent |
| 11/126 | Factors II and X Concentrate (4th International standard) WHO International Standard |
| 11/130 | Influenza Virus Infectious NIBRG-14 Influenza Reagent |
| 11/134 | Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived) Influenza Reagent |
| 11/170 | Erythropoietin, recombinant, for Bioassay (3rd International Standard) WHO International Standard |
| 11/176 | (3rd International Standard) Low Molecular Weight Heparin WHO International Standard |
| 11/184 | High Molecular Weight Urokinase(2nd International Standard) WHO International Standard |
| 11/206 | Influenza anti-A/Perth/16/2009 HA Serum Influenza Reagent |
| 11/210 | Anti-human CD4 FITC conjugated 0.5ml CE Marked Material |
| 11/214 | Blood Group Genotyping Reference Panel ((International Reference Reagent) International Reference Reagent |
| 11/216 | Chagas Antibody Reference Panel ( 1st International Standard) WHO International Standard |
| 11/218-001 | MLH1/MSH2 Exon Copy Number Reference Panel CE Marked Material |
| 11/222 | Influenza Virus Infectious NIB-79 Influenza Reagent |
| 11/226 | Influenza Virus Infectious A/Victoria/361/2011 Influenza Reagent |
| 11/232 | Influenza Virus Infectious B/Texas/6/2011 Influenza Reagent |
| 11/234 | Immunoglobulin E(IgE) human serum (3rd International Standard) WHO International Standard |
| 11/242-001 | Viral Multiplex Reference Non WHO Reference Material |
| 11/244 | Influenza Virus Infectiious NYMC BX-49 Influenza Reagent |
| 11/B604-002 | QCRFLUAH5QC1 Influenza H5 PC1 Quality Control Reagent |
| 11/B606-06 | QCRNEGQC1-Negative Quality Control Serum: Sample1 Quality Control Reagent |
| 11/B608-02 | QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 Quality Control Reagent |
| 12/100 | Influenza Virus Infectious NYMC X-217 Influenza Reagent |
| 12/104 | International Standard for IPV 12/104 (3rd International Standard) WHO International Standard |
| 12/106 | Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39) Influenza Reagent |
| 12/110 | Influenza Antigen B/Wisconsin/1/2010 (cell derived) Influenza Reagent |
| 12/112 | Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187) Influenza Reagent |
| 12/114 | Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165) Influenza Reagent |
| 12/116 | Influenza anti-A/Victoria/361/2011-like HA serum Influenza Reagent |
| 12/118 | Influenza anti-B/Wisconsin/1/2010-like HA serum Influenza Reagent |
| 12/122 | Influenza virus infectious A/turkey/Italy/3889/1999 Influenza Reagent |
| 12/154 | Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard) WHO International Standard |
| 12/176 | Methylated Human Serum Albumin (mHSA) Non WHO Reference Material |
| 12/188 | Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (International Standard) WHO International Standard |
| 12/198 | Influenza virus infectious B/Wisconsin/1/2010 34490 E5 Influenza Reagent |
| 12/202 | Influenza virus infectious NYMC BX-39 Influenza Reagent |
| 12/204 | Influenza Virus infectious IVR-165 Influenza Reagent |
| 12/208 | Parvovirus B19 (3rd International Standard) WHO International Standard |
| 12/224 | HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation) International Reference Preparation |
| 12/226 | HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard) WHO International Standard |
| 12/252 | ADAMTS 13 Plasma (1st International Standard) WHO International Standard |
| 12/282 | Diphtheria Toxin 1Lf/ml Non WHO Reference Material |
| 12/284 | Anti-meningococcal serogroup Y monoclonal antibody Non WHO Reference Material |
| 12/290 | Influenza Virus Infectious B/Brisbane/36/2012 Influenza Reagent |
| 12/294 | Influenza Virus Infectious NYMC BX-51C Influenza Reagent |
| 12/298 | Influenza Virus Infectious A/Texas/50/2012 Influenza Reagent |
| 12/306 | Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard) WHO International Standard |
| 12/B611-03 | Anti-VZV Quality control serum: Sample 1 QCRVZV IgM QC1 Quality Control Reagent |
| 12/B612-05 | QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1 Quality Control Reagent |
| 12/B613-04 | QCRRUBQC2-Anti-Rubella: Quality Control Serum: Sample 2 Quality Control Reagent |
| 12/B620-05 | QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2 Quality Control Reagent |
| 13/100 | Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard) WHO International Standard |
| 13/102-001 | Hepatitis A Virus RNA Working Reagent Clinical Virology Network CVN |
| 13/106 | Influenza Antigen B/Massachusetts/02/2012 Influenza Reagent |
| 13/108 | Anti-Meningococcal serogroup B monoclonal antibody Non WHO Reference Material |
| 13/112 | Influenza Antigen A/Texas/50/2012 (NYMC X-223) Influenza Reagent |
| 13/116 | Influenza Antigen A/Texas/50/2012 (NYMC X-223A) Influenza Reagent |
| 13/122 | Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel) WHO International Standard |
| 13/126 | Influenza anti-B/Brisbane/60/2008-like HA serum Influenza Reagent |
| 13/132 | Antibodies, Human, to Toxoplasma gondii (4th International Standard). WHO International Standard |
| 13/134 | Influenza Antigen B/Massachusetts/02/2012 (Egg derived) Influenza Reagent |
| 13/146 | C-Peptide, Human (1st International Standard). WHO International Standard |
| 13/152 | Influenza Antigen B/Massachusetts/02/2012 (cell derived) Influenza Reagent |
| 13/162 | Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived) Influenza Reagent |
| 13/164 | Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A) Influenza Reagent |
| 13/166 | Influenza anti-A/Anhui/1/2013 (N9) NA Serum Influenza Reagent |
| 13/168-002 | Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 13/172 | Lupus Anticoagulant (1st International Reference Panel) International Reference Preparation |
| 13/176 | Influenza Virus Infectious NIBRG-88 Influenza Reagent |
| 13/178 | Influenza Anti-A/Texas/50/2012-like HA Serum Influenza Reagent |
| 13/182 | Influenza Anti-B/Massachusetts/02/2012-like HA Serum Influenza Reagent |
| 13/198 | Influenza Virus Infectious NYMC X-181 Influenza Reagent |
| 13/200 | Influenza Virus Infectious NIB-74 Influenza Reagent |
| 13/202 | Influenza Virus Infectious NIB-74xp Influenza Reagent |
| 13/204 | TNF Rec II- FC Fusion protein (1st International Standard) WHO International Standard |
| 13/206 | Plasmin (4th International Standard) WHO International Standard |
| 13/212 | Diphtheria Toxoid for use in Flocculation Test (3rd International Standard) WHO International Standard |
| 13/214 | HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel) International Reference Preparation |
| 13/216 | Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal Non WHO Reference Material |
| 13/218 | Polio Anti Sabin type 1 (inactivated) Serum Non WHO Reference Material |
| 13/220 | Polio Anti Sabin type 2 (inactivated) serum Non WHO Reference Material |
| 13/222 | Polio Anti Sabin type 3 (inactivated) serum Non WHO Reference Material |
| 13/224 | Influenza virus Infectious NIB-85. 36210 E5 Influenza Reagent |
| 13/228 | Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4 Influenza Reagent |
| 13/234 | Influenza antigen B/Brisbane/60/08 Influenza Reagent |
| 13/238 | Anti-EV71 serum LOW (WHO International Reference Reagent) WHO International Standard |
| 13/242 | FEIBA Concentrate 2nd NIBSC Working Reference Standard Working Standard |
| 13/246 | Meningococcal serogroup A polysaccharide (1st WHO International Standard). WHO International Standard |
| 13/248 | Influenza virus infectious NIBRG-267 Influenza Reagent |
| 13/250 | Influenza Virus Infectious NIBRG-268 Influenza Reagent |
| 13/252 | Influenza virus infectious NYMC X-223A Influenza Reagent |
| 13/256 | Influenza virus infectious. NYMC x-233 Influenza Reagent |
| 13/258 | Influenza virus infectious NYMC X-233A Influenza Reagent |
| 13/264 | Influenza Virus Infectious NYMC X-223 Influenza Reagent |
| 13/B625-05 | QCRHBsGQC2-HBsAg Quality Control Serum: Sample2 Quality Control Reagent |
| 13/B627-04 | QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1 Quality Control Reagent |
| 13/B629-04 | QCRHBeQC1-Anti-HBe Quality Control Serum: sample1 Quality Control Reagent |
| 13/B631-04 | QCRHBsGQC1-HBsAg Quality Control Serum: Sample1 Quality Control Reagent |
| 13/B634-03 | QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2 Quality Control Reagent |
| 13/B636-04 | QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2 Quality Control Reagent |
| 13/B640-01 | QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5 Quality Control Reagent |
| 13/B642-06 | QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1 Quality Control Reagent |
| 13/B644-02 | QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3 Quality Control Reagent |
| 13/B650-02 | QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1 Quality Control Reagent |
| 14/106 | Influenza virus infectious. NYMC BX-51B Influenza Reagent |
| 14/114 | JC Virus (JCV) DNA (1st International Standard) WHO International Standard |
| 14/116 | Influenza virus infectious NYMC X-179A Influenza Reagent |
| 14/118 | Influenza virus infectious B/Massachusetts/2/2012 Influenza Reagent |
| 14/140 | 1st International Standard for Anti EV71 Serum Human WHO International Standard |
| 14/144 | Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) Influenza Reagent |
| 14/146 | Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived) Influenza Reagent |
| 14/148 | Human Blood Factor IX Concentrate (5th International Standard). WHO International Standard |
| 14/150 | Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015) WHO International Standard |
| 14/156 | Meningococcal group X polysaccharide (1st WHO International Standard) WHO International Standard |
| 14/160 | High titre anti-A in IVIG working reference reagent Working Standard |
| 14/174 | Botulinum Type A Antitoxin, Equine Non WHO Reference Material |
| 14/198-003 | HBV,HCV,HIV Multiplex CE Marked Material |
| 14/200 | Influenza Antigen A/Puerto Rico/8/34 (HINI) Influenza Reagent |
| 14/204 | Influenza Virus Infectious B/Brisbane/9/2014 Influenza Reagent |
| 14/206 | Influenza virus infectious NYMC X-247 Influenza Reagent |
| 14/212 | BK Virus (BKV)(1st International Standard) WHO International Standard |
| 14/224 | Influenza virus infectious. A/Switzerland/9715293/2013 Influenza Reagent |
| 14/226 | Influenza Virus Infectious A/South Australia/55/2014 Influenza Reagent |
| 14/228 | Influenza Virus Infectious A/Stockholm/6/2014 Influenza Reagent |
| 14/230 | Influenza Virus Infectious. A/Norway/466/2014 Influenza Reagent |
| 14/232 | Influenza Virus Infectious IVR-175 Influenza Reagent |
| 14/240-004 | British Working Standard for Anti-HCV CE Marked Material |
| 14/242-003 | Anti-HCV (1 in 8 dilution)(British Working Standard) CE Marked Material |
| 14/246 | Influenza Virus Infectious NIBRG-301 Influenza Reagent |
| 14/254 | Influenza Antigen A/Switzerland/9715293/2013 (NIB88) Influenza Reagent |
| 14/274 | Influenza Antigen B/Brisbane/9/2014 (Egg Derived) Influenza Reagent |
| 14/290 | 4th HCV RNA Genotype Panel for Nucleic Acid Amplification Non WHO Reference Material |
| 14/300 | High titre anti-A and anti-B in serum (WHO Reference Reagent). WHO International Standard |
| 14/306 | Influenza Virus Infectious NYMC X-243 40180 E13 Influenza Reagent |
| 14/308 | Influenza Virus Infectious IVR-178 40200 E7 Influenza Reagent |
| 14/312 | Influenza Virus Infectious B/Phuket/3073/2013 Influenza Reagent |
| 14/314 | Influenza Virus Infectious NIB-88 Influenza Reagent |
| 14/320 | Influenza Virus Infectious B/Utah/9/2014 Influenza Reagent |
| 14/322 | Influenza Virus Infectious NIB-91 Influenza Reagent |
| 14/B651-02 | QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2 Quality Control Reagent |
| 14/B653-01 | QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3 Quality Control Reagent |
| 14/B654-02 | QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1 Quality Control Reagent |
| 14/B655-02 | QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1 Quality Control Reagent |
| 15/100 | Influenza Antigen B/Utah/9/2014 (Cell Derived) Influenza Reagent |
| 15/104 | Influenza Antigen A/South Australia/55/2014 Cell derived Influenza Reagent |
| 15/106 | Ancrod WHO International Standard |
| 15/130-001 | Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT) Clinical Virology Network CVN |
| 15/134 | Influenza Anti-A Switzerland/9715293/2013-Like HA serum Influenza Reagent |
| 15/136 | EBOV RNA NP-VP35-GP in-run control International Reference Reagent |
| 15/138 | EBOV RNA VP40-L in-run control International Reference Reagent |
| 15/140 | Batroxobin Non WHO Reference Material |
| 15/146 | Influenza Virus Infectious B/Brisbane/60/2008 Influenza Reagent |
| 15/148 | Influenza Virus Infectious NIB-92 Influenza Reagent |
| 15/150 | Influenza anti-B/Phuket/3073/2013 HA serum Influenza Reagent |
| 15/154 | Influenza Virus Infectious NIB-93 Influenza Reagent |
| 15/158 | Influenza Virus Infectious NYMC X-263 Influenza Reagent |
| 15/160 | Influenza Virus Infectious NIBRG-306 Influenza Reagent |
| 15/180 | Blood Coagulation Factor XI, Plasma Human 2nd IS WHO International Standard |
| 15/184 | Influenza Virus Infectious NYMC X-263B Influenza Reagent |
| 15/188 | Influenza Virus Infectious NYMC X-263A Influenza Reagent |
| 15/192 | Influenza Virus Infectious A/Hong Kong/4801/2014 Influenza Reagent |
| 15/194 | Influenza Virus Infectious NYMC X-257A Influenza Reagent |
| 15/196 | Influenza Virus Infectious NYMC X-261 Influenza Reagent |
| 15/212 | Influenza Virus Infectious NYMC BX-53C Influenza Reagent |
| 15/220 | Anti-EBOV plasma, human (WHO Reference Reagent) International Reference Reagent |
| 15/222 | EBOV RNA NP-VP35-GP (WHO Reference Reagent) International Reference Reagent |
| 15/224 | EBOV RNA VP40-L (WHO Reference Reagent) International Reference Reagent |
| 15/234 | Influenza Virus Infectious B/Texas/2/2013 41340 E7 Influenza Reagent |
| 15/238 | Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen) Influenza Reagent |
| 15/240 | Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel) WHO International Standard |
| 15/242 | Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel) WHO International Standard |
| 15/250 | Influenza Virus Infectious NYMC BX-31 Influenza Reagent |
| 15/252 | Influenza Virus Infectious A/California/7/2009 Influenza Reagent |
| 15/274 | Influenza Virus Infectious NYMC BX-59A Influenza Reagent |
| 15/294 | Influenza virus infectious NYMC BX-59B Influenza Reagent |
| 15/298 | Influenza Virus Infectious B/Brisbane/46/2015 Influenza Reagent |
| 15/300 | Influenza Virus Infectious NYMC BX-35 41950 E11 Influenza Reagent |
| 15/312 | Influenza Anti-B/Brisbane/60/2008 HA Serum Influenza Reagent |
| 15/B658-02 | QCRLYMEQC1 - Anti-Lyme QC1 Quality Control Reagent |
| 15/B661-02 | QCRLYMEIgMQC1 - IgM Anti-Lyme QC1 Quality Control Reagent |
| 15/B664-02 | QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1 Quality Control Reagent |
| 15/B667-02 | QCRMEASQC1 Anti-MeaslesQC1 Quality Control Reagent |
| 15/B669-02 | QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 Quality Control Reagent |
| 15/B671-01 | QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1 Quality Control Reagent |
| 15/B673-01 | QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 Quality Control Reagent |
| 15/B675-02 | QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2 Quality Control Reagent |
| 15/B678-01 | QCRPARVB19QC1 Anti-Parvovirus B19QC1 Quality Control Reagent |
| 15/B680-01 | QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1 Quality Control Reagent |
| 16/104-001 | Norovirus GII Working reagent for Nucleic Acid Amplification Techniques Clinical Virology Network CVN |
| 16/106 | Influenza antigen A/California/7/09 (H1N1) (NYMC-X181) Influenza Reagent |
| 16/110-001 | Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT) Clinical Virology Network CVN |
| 16/114 | Influenza anti - A/California/7/09 HA serum Influenza Reagent |
| 16/118 | Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived) Influenza Reagent |
| 16/120 | WHO 1st International Reference Panel for Genomic JAK2 V617F WHO International Standard |
| 16/124-001 | Zika Virus run Control (NAT) Clinical Virology Network CVN |
| 16/158 | Influenza Antigen B/Phuket/3073/2013 Influenza Reagent |
| 16/166 | Diphtheria Antitoxin Equine DI. WHO International Standard |
| 16/182 | Influenza Anti-A/Hong Kong/4801/2014-like HA Serum Influenza Reagent |
| 16/200 | Influenza Virus Infectious NIB-58 Influenza Reagent |
| 16/208 | Influenza Virus Infectious NIB-97 42090 E7 Influenza Reagent |
| 16/242 | Influenza Virus Infectious NIB-98 42110 E7 Influenza Reagent |
| 16/248 | Influenza Virus Infectious NYMC X-275 42020 E11 Influenza Reagent |
| 16/268 | Influenza Virus Infectious X-273 Influenza Reagent |
| 16/270 | Influenza Virus Infectious IVR-180 42400 E3/D7/E1 Influenza Reagent |
| 16/274 | Influenza Virus Infectious X-275A 42010 E13 Influenza Reagent |
| 16/282 | Influenza Virus Infectious X-285 42430 ExE1 Influenza Reagent |
| 16/286 | Influenza Antigen A/Hong Kong/4801/2014 (NYMC X-263B) Influenza Reagent |
| 16/288 | Influenza Virus Infectious X-283A 42420 ExE1 Influenza Reagent |
| 16/290 | Influenza Virus Infectious X-285A 42440 ExE1 Influenza Reagent |
| 16/292 | Influenza Antigen A/Singapore/GP1908/2015 (IVR-180) Influenza Reagent |
| 16/298 | Influenza Antigen A/Michigan/45/2015 (NYMC X-275) Influenza Reagent |
| 16/304 | Influenza anti-A/Michigan/45/2015-like HA serum Influenza Reagent |
| 16/354 | Influenza Virus Infectious A/Michigan/45/2015 41710 E4 Influenza Reagent |
| 16/360 | Influenza Virus Infectious NIB-96 41920 E7 Influenza Reagent |
| 16/362 | Influenza Virus Infectious NYMC X-291 42530 E8 Influenza Reagent |
| 16/366 | Influenza Virus Infectious NYMC X-291A 42540 E8 Influenza Reagent |
| 16/B683-02 | QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1 Quality Control Reagent |
| 16/B685-02 | QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2 Quality Control Reagent |
| 16/B687-01 | QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices Quality Control Reagent |
| 16/B704-01 | QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1 Quality Control Reagent |
| 234 | IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234) Non WHO Reference Material |
| 2BADS | Anti-Brucella Abortus Serum, Bovine (International Standard) WHO International Standard |
| 2CPBETAAT | Clostridium Perfringens Beta Antitoxin (2nd International Standard) WHO International Standard |
| 2CPEPSILONAT | Clostridium Perfringens Epsilon Antitoxin (2nd International Standard) WHO International Standard |
| 520 | IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520) Non WHO Reference Material |
| 59/015 | Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine Non WHO Reference Material |
| 59/016 | Corticotrophin (ACTH), Porcine (3rd International Standard) WHO International Standard |
| 59/021 | Botulinum Antitoxin Equine Type A Non WHO Reference Material |
| 60/001 | Botulinum Antitoxin Equine Type B Non WHO Reference Material |
| 60/013 | Tetanus Antitoxin, Equine, for Bioassay Non WHO Reference Material |
| 61/001 | Botulinum Antitoxin Equine Type D (1st International Standard) WHO International Standard |
| 62/001 | Serum Gonadotrophin, Equine (2nd International Standard) WHO International Standard |
| 62/014 | Lysine Vasopressin, Porcine Non WHO Reference Material |
| 63/005 | Gas Gangrene Antitoxin (Cl. Histolyticum), Equine Non WHO Reference Material |
| 63/007 | Diphtheria Antitoxin, Equine, for Flocculation Test Non WHO Reference Material |
| 64/002 | Rheumatoid Arthritis Serum Non WHO Reference Material |
| 64/014 | Gas Gangrene Antitoxin (Cl. Septicum), Equine Non WHO Reference Material |
| 64/024 | Gas Gangrene Antitoxin (Cl. Oedematiens), Equine Non WHO Reference Material |
| 65/093 | Anti-Thyroglobulin Serum, Human (International Reference reagent) International Reference Preparation |
| 65/119 | Renin, Porcine Non WHO Reference Material |
| 65/122 | Long-acting Thyroid Stimulator, Human Non WHO Reference Material |
| 66/021 | Tetanus Antitoxin, Equine, for Flocculation Test Non WHO Reference Material |
| 66/138 | Gastrin II, Porcine Non WHO Reference Material |
| 66/153 | Diphtheria Antitoxin, Equine Non WHO Reference Material |
| 66/233 | Anti-Nuclear Factor Serum (Homogenous) Human Non WHO Reference Material |
| 66/387 | Anti-thyroid Microsome Serum, Human Non WHO Reference Material |
| 67/037 | Immunoglobulin D (IgD) Serum, Human Non WHO Reference Material |
| 67/086 | Immunoglobulins G, A, M Serum Human (International Standard) WHO International Standard |
| 67/099 | Immunoglobulins G, A & M Serum Human Non WHO Reference Material |
| 67/182 | Anti-Rubella Serum, Human CE Marked Material |
| 67/183 | Primary Biliary Cirrhosis Serum, Human Non WHO Reference Material |
| 68/340 | Anti-Nucleolar Factor Plasma, Human Non WHO Reference Material |
| 68/356 | Renin, Human (International Standard) WHO International Standard |
| 69/017 | Diphtheria Toxoid, Plain Non WHO Reference Material |
| 69/065 | Autoimmune Antibody to Human Spermatazoa Non WHO Reference Material |
| 69/194 | Glucagon, Porcine (First International Standard) WHO International Standard |
| 70/302 | Angiotensin II (25µg) Non WHO Reference Material |
| 71/281 | Anti-Malaria Plasma P Vivax Non WHO Reference Material |
| 71/326 | Anti-Malaria Plasma Vivax Ng2 Non WHO Reference Material |
| 71/328 | Angiotensin I Non WHO Reference Material |
| 72/092 | Anti-malaria Plasma: Plasmodium falciparum (Ghana) Non WHO Reference Material |
| 72/096 | Anti-Malaria Serum (P.Malariae) Non WHO Reference Material |
| 72/341 | Anti-Malaria Plasma P Falciparum Non WHO Reference Material |
| 72/345 | Anti-Malaria Plasma P Falciparum Non WHO Reference Material |
| 72/348 | Anti-Malaria Plasma P Vivax Non WHO Reference Material |
| 73/515 | Anti-D (Rho) Antibodies, Human CE Marked Material |
| 73/545 | Placental Lactogen, Human (International Reference Preparation) WHO International Standard |
| 73/554 | Cholera Vaccine (Inaba) Non WHO Reference Material |
| 73/556 | Cholera Vaccine (Ogawa) Non WHO Reference Material |
| 73/601 | Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation) WHO International Standard |
| 74/520 | Serum Proteins (Other than Immunoglobulins) Human Non WHO Reference Material |
| 74/555 | Corticotrophin (ACTH), Human Non WHO Reference Material |
| 74/586 | Corticotrophin (ACTH), Porcine (International Working Standard) WHO International Standard |
| 75/506 | Cocksfoot Pollen Extract Non WHO Reference Material |
| 75/533 | Chorionic Gonadotrophin, Human, for Radioiodination Non WHO Reference Material |
| 75/535 | Chorionic Gonadotrophin beta, Human, for Radioiodination Non WHO Reference Material |
| 75/551 | Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation) International Reference Preparation |
| 75/569 | Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation) International Reference Preparation |
| 75/595 | Blood Coagulation Factor Xa, Bovine Non WHO Reference Material |
| 76/508 | Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination Non WHO Reference Material |
| 76/515 | Mannan (C. Albians) Purified Non WHO Reference Material |
| 76/522 | Opacity 5IRP WHO International Standard WHO International Standard |
| 76/525 | Anti-Birch Pollen Serum, Human Non WHO Reference Material |
| 76/547 | Influenza anti A/Victoria/3/75 Serum(goat) Influenza Reagent |
| 76/575 | Oxytocin(4th International Standard) WHO International Standard |
| 77/503 | Anti-Cocksfoot Serum, Human Non WHO Reference Material |
| 77/512 | Lysine Vasopressin(1st International Standard) WHO International Standard |
| 77/531 | Influenza anti A/New Jersey/8/76(H1N1) Serum Influenza Reagent |
| 77/568 | Influenza anti B/Hong Kong/8/73 Serum Influenza Reagent |
| 77/584 | Anti-D Pteronyssinus Serum, Human Non WHO Reference Material |
| 77/600 | Mannan (C. Albicans) Purified Non WHO Reference Material |
| 77/616 | Twelve Grass Pollen Extract Non WHO Reference Material |
| 77/643 | Secretin Non WHO Reference Material |
| 77/662 | Acarus Siro Extract Non WHO Reference Material |
| 77/664 | Glycyphagus destructor Extract Non WHO Reference Material |
| 78/517 | Tyrophagus Putrescentiae Extract Non WHO Reference Material |
| 78/543 | Kininogenase (Porcine, Pancreatic) (Formerly 1st International Standard) WHO International Standard |
| 78/545 | Anti-Aspergillus fumigatus Serum, Human Non WHO Reference Material |
| 78/554 | Luteinizing Hormone, Pituitary, alpha subunit (International Standard) WHO International Standard |
| 78/556 | Luteinizing Hormone, Pituitary, beta subunit (International standard) WHO International Standard |
| 78/560 | Influenza Antigen A/Texas/1/77 Influenza Reagent |
| 78/569 | Influenza anti A/Texas/1/77 Serum Influenza Reagent |
| 78/575 | Aspergillus Fumigatus Extract Non WHO Reference Material |
| 78/582 | Tyrophagus Longior Extract Non WHO Reference Material |
| 78/628 | Bee Venom Non WHO Reference Material |
| 79/500 | Parathyroid Hormone, Human (1st International Ref. Preparation) International Reference Preparation |
| 79/516 | Influenza anti A/Brazil/11/78 Serum (goat) Influenza Reagent |
| 79/552 | Influenza Antigen A/USSR/92/77 Influenza Reagent |
| 79/558 | Influenza Antigen A/USSR/92/77 Influenza Reagent |
| 79/560 | Influenza Antigen A/Brazil/11/78 Influenza Reagent |
| 79/568 | Influenza Antigen B/Hong Kong/8/73 Influenza Reagent |
| 79/572 | Prekallikrein Activator (PKA), Human Non WHO Reference Material |
| 80/505 | Growth Hormone, Human, Pituitary. WHO International Standard WHO International Standard |
| 80/517 | Influenza Antigen A/Bangkok/1/79 Influenza Reagent |
| 80/519 | Influenza Antigen B/Singapore/222/79 Influenza Reagent |
| 80/523 | Influenza anti B/Singapore/222/79 Serum Influenza Reagent |
| 80/525 | Influenza anti A/Bangkok/1/79 Serum Influenza Reagent |
| 80/590 | Tetracosactide. International Ref. Preparation International Reference Preparation |
| 81/535 | Luteinizing Hormone, Human, Pituitary (3rd International Standard) WHO International Standard |
| 81/565 | Thyroid Stimulating Hormone, Human. WHO International Standard WHO International Standard |
| 82/508 | Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment Non WHO Reference Material |
| 82/512 | Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment Non WHO Reference Material |
| 82/518 | Dermatophagoides Pteronyssinus Extract. WHO International Standard WHO International Standard |
| 82/520 | Timothy Pollen Extract. WHO International Standard WHO International Standard |
| 82/585 | Anti Poliovirus serum types 1,2 and 3 (3rd International Standard) WHO International Standard |
| 82/587 | Interferon Gamma (Human, Leukocyte derived) Non WHO Reference Material |
| 82/632 | Parathyroid Hormone, Bovine. WHO International Standard WHO International Standard |
| 82/652 | Human Serum Vitamin B12, Pernicous anaemia Non WHO Reference Material |
| 83/500 | Insulin, Human. WHO International Standard WHO International Standard |
| 83/501 | Beta Thromboglobulin, Purified Human. WHO International Standard WHO International Standard |
| 83/505 | Platelet Factor 4 Human, Purified. WHO International Standard WHO International Standard |
| 83/511 | Insulin, Bovine. WHO International Standard WHO International Standard |
| 83/514 | Interferon alpha-1D, (Human rDNA derived) WHO International Standard WHO International Standard |
| 83/515 | Insulin, Porcine. WHO International Standard WHO International Standard |
| 83/537 | Influenza Antigen A/Philippines/2/82 Influenza Reagent |
| 83/545 | Influenza anti A/Philippine/2/82 Serum Influenza Reagent |
| 83/550 | Influenza Antigen A/Brazil/11/78 Influenza Reagent |
| 83/573 | Prolactin, Human (4th WHO International Standard.) WHO International Standard |
| 83/575 | Follicle Stimulating Hormone, Pituitary. WHO International Standard WHO International Standard |
| 84/514 | Proinsulin, Bovine. International Ref. Preparation International Reference Preparation |
| 84/522 | Birch Pollen Extract. WHO International Standard WHO International Standard |
| 84/528 | Proinsulin, Porcine. International Ref. Reagent International Reference Reagent |
| 84/538 | Influenza Antigen A/Chile/1/83 Influenza Reagent |
| 84/542 | Influenza Antigen B/Norway/1/84 Influenza Reagent |
| 84/581 | Short Ragweed Pollen Extract. WHO International Standard WHO International Standard |
| 84/614 | Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin) WHO International Standard WHO International Standard |
| 84/628 | Anti-c Serum, Human CE Marked Material |
| 84/636 | Influenza anti B/USSR/100/83 Serum Influenza Reagent |
| 84/640 | Influenza anti A/Chile/1/8 Serum Influenza Reagent |
| 84/677 | Influenza anti A/equine/Miami/63 (H3N8) Serum(goat) Influenza Reagent |
| 84/685 | Dog (Canis Familiaris) Hair Dander Extract. WHO International Standard WHO International Standard |
| 85/506 | C-Reactive Protein, Human. WHO International Standard WHO International Standard |
| 85/516 | Influenza anti A/Equine/Kentucky/1/81 HA Serum Influenza Reagent |
| 85/520 | Influenza Antigen A/Equine/Kentucky/1/81 Influenza Reagent |
| 85/522 | Thyroid Stimulating Hormone beta subunit Non WHO Reference Material |
| 85/551 | Anti-Rye Grass Serum, Human Non WHO Reference Material |
| 85/616 | Haemoglobin F Lysate, Raised. WHO Reference Reagent WHO International Standard |
| 85/669 | Atrial Natriuretic Factor, Human. WHO International Standard WHO International Standard |
| 86/500 | Interleukin- 2 (Human, rDNA derived)(2nd International Standard) WHO International Standard |
| 86/536 | Angiotensin I Human Type Synthetic Non WHO Reference Material |
| 86/538 | Angiotensin II (2.5µg) Non WHO Reference Material |
| 86/552 | Interleukin-1 Beta (Human, rDNA derived) Non WHO Reference Material |
| 86/576 | Influenza Antigen A/Mississippi/1/85 Influenza Reagent |
| 86/590 | Influenza anti A/Mississippi/1/85 Serum Influenza Reagent |
| 86/592 | Influenza anti B/Ann Arbor/1/86/HA Serum Influenza Reagent |
| 86/630 | Influenza Antigen B/Ann Arbor/1/86 Influenza Reagent |
| 86/632 | Interleukin-1 alpha (Human rDNA derived) WHO International Standard WHO International Standard |
| 86/678 | Interleukin-1 alpha (Human, rDNA derived) Non WHO Reference Material |
| 86/680 | Interleukin-1 beta (Human, rDNA derived) WHO International Standard WHO International Standard |
| 86/690 | Inhibin, Porcine WHO International Standard WHO International Standard |
| 87/510 | Influenza Antigen A/Equine/Miami/63 Influenza Reagent |
| 87/578 | Influenza anti A/Leningrad/360/86 Serum Influenza Reagent |
| 87/584 | Influenza Antigen A/Leningrad/360/86 Influenza Reagent |
| 87/586 | Interferon Gamma (Human, rDNA derived) Non WHO Reference Material |
| 87/640 | Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 87/654 | Anti-Ferritin Monoclonal Antibody (1) Non WHO Reference Material |
| 87/662 | Anti-Ferritin Monoclonal Antibody (2) Non WHO Reference Material |
| 87/714 | Influenza Antigen A/Sichuan/2/87 Influenza Reagent |
| 87/774 | Influenza Antigen B/Victoria/2/87 Influenza Reagent |
| 88/522 | Bordetella pertussis (Whole cell vaccine) 3BRP Non WHO Reference Material |
| 88/532 | Tumour Necrosis Factor alpha (Mouse, rDNA derived) Non WHO Reference Material |
| 88/554 | Influenza Antigen B/Beijing/1/87 Influenza Reagent |
| 88/556 | Calcitonin, Eel WHO International Standard WHO International Standard |
| 88/638 | Thyroxine-binding globulin. WHO International Standard WHO International Standard |
| 88/646 | Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard WHO International Standard |
| 88/654 | Influenza Antigen A/England/427/88 Influenza Reagent |
| 88/656 | Interleukin-4 (Human, rDNA derived) WHO International Standard WHO International Standard |
| 88/672 | Influenza anti A/Sichuan/2/87 Serum Influenza Reagent |
| 88/678 | Influenza anti B/Beijing/1/87 Serum Influenza Reagent |
| 88/846 | Influenza anti A/England/427/88 Serum Influenza Reagent |
| 89/512 | Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived) WHO International Standard WHO International Standard |
| 89/514 | Transforming Growth Factor beta-1 (Human, rDNA derived) Non WHO Reference Material |
| 89/516 | Transforming Growth Factor beta-1 (Bovine) Non WHO Reference Material |
| 89/518 | Transforming Growth Factor beta-2 (Bovine) Non WHO Reference Material |
| 89/520 | Interleukin-8 (Human, rDNA derived) WHO International Standard WHO International Standard |
| 89/530 | Anti-Bordetella pertussis serum (Human) Non WHO Reference Material |
| 89/544 | Renin, Human, rec DNA Non WHO Reference Material |
| 89/548 | Interleukin-6 (Human, rDNA derived) WHO International Standard WHO International Standard |
| 89/568 | Influenza Antigen A/OMS/5389/88 Influenza Reagent |
| 89/594 | Bordetella pertussis (W28) LPS 2ug Non WHO Reference Material |
| 89/596 | Bordetella pertussis anti-agglutinogen 1(rabbit) Non WHO Reference Material |
| 89/598 | Bordetella pertussis anti-agglutinogen 2 (rabbit) Non WHO Reference Material |
| 89/600 | Bordetella pertussis anti-agglutinogen 3 (rabbit) Non WHO Reference Material |
| 89/620 | Calcitonin, Human. WHO International Standard WHO International Standard |
| 89/666 | Haemoglobin A2 Lysate, Raised. WHO Reference Reagent International Reference Reagent |
| 89/670 | Bordetella pertussis (W28) LPS25ug Non WHO Reference Material |
| 90/500 | Influenza Antigen A/Shanghai/16/89 Influenza Reagent |
| 90/502 | Influenza Antigen A/Guizhou/54/89 Influenza Reagent |
| 90/504 | Influenza anti A/Guangdong/39/89 Serum Influenza Reagent |
| 90/520 | Bordetella pertussis, filamentous haemagglutinin (FHA) Non WHO Reference Material |
| 90/530 | Interleukin-7 (Human, rDNA derived) WHO Reference Reagent International Reference Reagent |
| 90/534 | Mumps Vaccine (Live) WHO Reference Reagent International Reference Reagent |
| 90/586 | Interleukin-5 (Human, rDNA derived) WHO Reference Reagent International Reference Reagent |
| 90/636 | HIV-1 P24 Antigen WHO International Standard WHO International Standard |
| 90/654 | Bordetella pertussis 69kD Non WHO Reference Material |
| 90/690 | Anti-Varicella-Zoster Antibody CE Marked Material |
| 90/696 | Transforming Growth Factor beta-2, Human, rec DNA Non WHO Reference Material |
| 90/712 | Basic Fibroblast Growth Factor (Human, rDNA derived) WHO International Standard WHO International Standard |
| 90/784 | Influenza Virus infectious NIB-26 (H3N2) Influenza Reagent |
| 91/510 | Interleukin-3 (Human, rDNA derived) WHO International Standard WHO International Standard |
| 91/530 | Epidermal Growth Factor (Human, rDNA derived) WHO International Standard WHO International Standard |
| 91/550 | Epidermal Growth Factor (1-52) (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 91/554 | Insulin-like growth Factor 1 WHO International Standard WHO International Standard |
| 91/562 | Anti-D for use with papain preparation 92/658 Working Standard |
| 91/612 | Influenza anti A/Taiwan/1/86 Serum Influenza Reagent |
| 91/624 | Inhibin A, Human, recombinant WHO International Standard WHO International Standard |
| 91/626 | Activin A, Human, Recombinant. WHO Reference Reagent WHO International Standard |
| 91/656 | Interleukin-4 (Mouse, rDNA derived) Non WHO Reference Material |
| 91/658 | Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived) Non WHO Reference Material |
| 91/662 | Interleukin-3 (Mouse, rDNA derived) Non WHO Reference Material |
| 91/670 | Influenza Virus infectious NIB-27 (H1N1) Influenza Reagent |
| 91/678 | Interleukin-9 (Human,rDNA derived) WHO Reference Reagent WHO International Standard |
| 91/682 | Stem Cell Factor (Human rDNA derived) WHO Reference Reagent WHO International Standard |
| 91/688 | Rubella Vaccine (Live) WHO Reference Reagent WHO International Standard |
| 92/510 | Follicle Stimulating Hormone, Human, recombinant. WHO International Standard WHO International Standard |
| 92/512 | Follicle Stimulating Hormone, urofollitropin Human Urinary WHO International Standard WHO International Standard |
| 92/518 | Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived) Non WHO Reference Material |
| 92/520 | Rantes (Human, rDNA derived) Non WHO Reference Material |
| 92/530 | Influenza Antigen A/Texas/36/91 Influenza Reagent |
| 92/582 | Influenza anti B/Yamagata/16/88 Serum Influenza Reagent |
| 92/628 | Influenza Antigen B/Yamagata/16/88 Influenza Reagent |
| 92/632 | Influenza anti A/Beijing/352/89 (H3N2) Serum Influenza Reagent |
| 92/644 | Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived) Non WHO Reference Material |
| 92/648 | Rubella Vaccine (Live) WHO Reference Reagent WHO International Standard |
| 92/654 | Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human WHO International Standard WHO International Standard |
| 92/658 | Papain preparation for use with Anti-D preparation 91/562 Working Standard |
| 92/680 | Serum amyloid A protein. WHO International Standard WHO International Standard |
| 92/734 | Influenza Virus infectious A/Beijing/32/92 (H3N2) Influenza Reagent |
| 92/738 | Influenza Virus infectious A/Shanghai/24/90 Influenza Reagent |
| 92/788 | Interleukin-11 (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 92/794 | Monocyte Chemoattractant Protein-1 (Human,rDNA derived) Non WHO Reference Material |
| 93/500 | Influenza Antigen A/Beijing/32/92 Influenza Reagent |
| 93/516 | Influenza Antigen A/Shanghai/24/90 Influenza Reagent |
| 93/518 | Influenza anti A/Beijing/32/92 (H3N2) Serum Influenza Reagent |
| 93/522 | Influenza anti A/Shanghai/24/90 (H3N2) Serum Influenza Reagent |
| 93/556 | Nerve Growth Factor (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 93/560 | Insulin-like growth Factor Binding Protein-3 Non WHO Reference Material |
| 93/562 | Leukaemia Inhibitory Factor (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 93/564 | Oncostatin M (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 93/566 | Interleukin-2 (Mouse, rDNA derived) Non WHO Reference Material |
| 93/568 | Influenza Virus infectious A/Beijing/359/89 (H3N2) Influenza Reagent |
| 93/572 | Influenza Virus infectious A/Guizhou/54/89 (H3N2) Influenza Reagent |
| 93/574 | Bone morphogenetic Protein-2 (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 93/668 | Interleukin-1 beta (Mouse, rDNA derived) Non WHO Reference Material |
| 93/672 | Interleukin-1 alpha (Mouse, rDNA derived) Non WHO Reference Material |
| 93/686 | Influenza Virus infectious A/Shangdong/9/93 (H3N2) Influenza Reagent |
| 93/692 | Influenza Virus infectious B/Panama/45/90 Influenza Reagent |
| 93/722 | Interleukin-10 (Human rDNA derived) WHO Reference Reagent WHO International Standard |
| 93/730 | Interleukin-6 (Mouse, rDNA derived) Non WHO Reference Material |
| 93/740 | Interleukin-7 (Mouse, rDNA derived) Non WHO Reference Material |
| 93/816 | Influenza Virus infectious A/Harbin/15/92 (H3N2) Influenza Reagent |
| 94/500 | Influenza Antigen B/Panama/45/90 Influenza Reagent |
| 94/504 | Influenza anti A/Shanghai/9/93 Serum Influenza Reagent |
| 94/516 | Influenza Antigen A/Shangdong/9/93 Influenza Reagent |
| 94/520 | Influenza anti B/Panama/45/90 Serum Influenza Reagent |
| 94/532 | Pertussis Vaccine (Whole Cell) WHO International Standard WHO International Standard |
| 94/572 | Ferritin, Human, recombinant. WHO International Standard WHO International Standard |
| 94/622 | Interleukin-13 (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 94/674 | Thyroid Stimulating Hormone, Human recombinant WHO Reference Reagent International Reference Reagent |
| 94/684 | Ciliary Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 94/718 | Staphylokinase, rec (STAR) Non WHO Reference Material |
| 94/728 | Platelet-derived Growth Factor-BB (Human, rDNA derived) WHO International Standard WHO International Standard |
| 94/730 | Tissue Plasminogen Activator (tPA) Antigen in Plasma WHO International Standard WHO International Standard |
| 94/754 | Interferon Omega (Human, rDNA derived) WHO International Standard WHO International Standard |
| 94/762 | Influenza Virus infectious RESVIR-8 (H3N2) Influenza Reagent |
| 94/766 | Influenza Virus infectious NIB-34 (H3N2) Influenza Reagent |
| 94/784 | Interferon alpha (Human, leukocyte derived)WHO International Standard WHO International Standard |
| 94/786 | Interferon alpha Concensus Sequence (Human rDNA derived) WHO International Standard WHO International Standard |
| 94/790 | MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100% 472-C WHO International Standard WHO International Standard |
| 95/510 | Influenza Antigen A/Texas/36/91 Influenza Reagent |
| 95/516 | Influenza Antigen A/Johannesburg/33/94 Influenza Reagent |
| 95/522 | Anti-HBc (Anti-hepatitis B core antigen) WHO International Standard WHO International Standard |
| 95/524 | Influenza anti A/Johannesburg/33/94 Serum Influenza Reagent |
| 95/528 | Folate, Whole Blood Haemolysate WHO International Standard WHO International Standard |
| 95/542 | MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C WHO International Standard WHO International Standard |
| 95/544 | Interleukin-12 (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 95/554 | Interleukin-15 (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 95/564 | Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc) Non WHO Reference Material |
| 95/566 | Interferon alpha-2b (Human, rDNA derived) WHO International Standard WHO International Standard |
| 95/568 | Interferon Alpha n1 (Human lymphoblastoid cell derived) WHO International Standard WHO International Standard |
| 95/572 | Interferon alpha-1/8 (Human, rDNA derived) WHO International Standard WHO International Standard |
| 95/574 | Interferon Alpha n3 (Human, leukocyte derived) WHO International Standard WHO International Standard |
| 95/580 | Interferon alpha-2c (Human, rDNA derived) WHO International Standard WHO International Standard |
| 95/584 | Anti-hepatitis E Serum, Human WHO Reference Reagent WHO International Standard |
| 95/646 | Parathyroid Hormone 1-84, human, recombinant (1st International Standard) WHO International Standard |
| 95/650 | Interferon alpha-2a (Human, rDNA derived) WHO International Standard WHO International Standard |
| 95/668 | Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc) Non WHO Reference Material |
| 95/674 | Anti-Meningococcal Serogroup A mAb Non WHO Reference Material |
| 95/678 | Anti-Meningococcal Serogroup C mAb Non WHO Reference Material |
| 96/528 | Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived) Non WHO Reference Material |
| 96/532 | FMS-like tyrosine kinase 3 ligand (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 96/534 | Brain-derived Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 96/538 | Insulin-like growth Factor-II (Human rDNA derived) WHO Reference Reagent WHO International Standard |
| 96/556 | Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived) WHO International Standard WHO International Standard |
| 96/564 | Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived) WHO Reference Reagent WHO International Standard |
| 96/572 | MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C WHO Reference Reagent WHO International Standard |
| 96/578 | MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C WHO Reference Reagent WHO International Standard |
| 96/602 | Luteinizing Hormone, Human, recombinant WHO International Standard WHO International Standard |
| 96/666 | Anti-Human Globulin International Reference Reagent WHO International Standard |
| 96/668 | Prostate Specific Antigen (free) WHO International Standard WHO International Standard |
| 96/784 | Inhibin B, Human WHO Reference Reagent WHO International Standard |
| 96/830 | Influenza Virus infectious A/Bayern/7/95 Influenza Reagent |
| 96/836 | Influenza Virus infectious RESVIR-9 (H3N2) Influenza Reagent |
| 96/848 | Influenza Virus infectious A/Shenzhen/227/95 (H1N1) Influenza Reagent |
| 96/850 | Influenza Virus infectious NIB-39 (H1N1) Influenza Reagent |
| 97/518 | Influenza Antigen A/Johannesburg/82/96 Influenza Reagent |
| 97/538 | Anti-Granulocyte Macrophage Colony Stimulating Factor Serum Non WHO Reference Material |
| 97/550 | Islet Cell Antibodies WHO Reference Reagent WHO International Standard |
| 97/558 | Bordetella pertussis anti 69kD serum (sheep) Non WHO Reference Material |
| 97/562 | Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.) WHO International Standard |
| 97/564 | Bordetella pertussis anti FHA serum (sheep) Non WHO Reference Material |
| 97/572 | Bordetella pertussis PT anti serum (sheep) Non WHO Reference Material |
| 97/574 | Bordetella pertussis anti Fim3 serum (sheep) Non WHO Reference Material |
| 97/584 | Influenza Antigen A/Equine/Newmarket/2/93 Influenza Reagent |
| 97/594 | Leptin, Human, Recombinant WHO International Standard WHO International Standard |
| 97/596 | Influenza Antigen A/Equine/Newmarket/1/93 Influenza Reagent |
| 97/600 | Interleukin-2 Soluble Receptor (human, rDNA derived) Non WHO Reference Material |
| 97/610 | Influenza anti A/equine/Newmarket/1/93 Serum Influenza Reagent |
| 97/612 | Influenza anti- A/Nanchang/933/95 (H3N2) HA serum Influenza Reagent |
| 97/614 | Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376) Influenza Reagent |
| 97/626 | Leptin, Mouse, Recombinant WHO International Standard WHO International Standard |
| 97/642 | Bordetella pertussis anti serum (mouse) 1RR WHO International Standard |
| 97/646 | Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard WHO International Standard |
| 97/648 | Anti-Measles serum (3rd International Standard) WHO International Standard |
| 97/692 | Influenza Virus infectious IVR-108 (H3N2) Influenza Reagent |
| 97/714 | Prolactin, Human, recombinant. WHO Reference Reagent WHO International Standard |
| 97/722 | Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3) Influenza Reagent |
| 97/726 | Influenza Virus infectious B/Harbin/7/94 Influenza Reagent |
| 97/748 | Influenza Antigen B/Harbin/7/94 Influenza Reagent |
| 97/756 | MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G. WHO Reference Reagent WHO International Standard |
| 97/758 | MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G WHO International Standard WHO International Standard |
| 97/760 | Influenza Antigen A/Beijing/262/95 Influenza Reagent |
| 98/524 | MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G WHO International Standard WHO International Standard |
| 98/544 | Influenza Virus infectious RESVIR-13 (H3N2) Influenza Reagent |
| 98/572 | Diphtheria and Tetanus Antitoxin, Guinea Pig Serum Non WHO Reference Material |
| 98/574 | Somatropin WHO International Standard WHO International Standard |
| 98/580 | Prolactin Human, recombinant, glycosylated WHO Reference Reagent WHO International Standard |
| 98/582 | Prolactin, Human, recombinant, non-glycosylated WHO Reference Reagent WHO International Standard |
| 98/586 | Calcitonin, Salmon. WHO International Standard WHO International Standard |
| 98/596 | MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G. WHO Reference Reagent WHO International Standard |
| 98/600 | Influenza Virus infectious NIB-40 (H5N3) Influenza Reagent |
| 98/604 | Influenza anti B/Harbin/7/94/HA Serum Influenza Reagent |
| 98/610 | Influenza Virus infectious ARIV-1 (H5N3) Influenza Reagent |
| 98/666 | Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep) Influenza Reagent |
| 98/686 | Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology) Non WHO Reference Material |
| 98/708 | Haemiglobincyanide WHO International Standard WHO International Standard |
| 98/714 | Tissue Plasminogen Activator, Human, Recombinant WHO International Standard WHO International Standard |
| 98/718 | Neurotrophin 3 Non WHO Reference Material |
| 98/722 | Meningococcal group A polysaccharide Non WHO Reference Material |
| 98/762 | Influenza Virus infectious Resvir-14 (H3N2) Influenza Reagent |
| 98/772 | Influenza anti A/Beijing/262/95 Serum Influenza Reagent |
| 98/774 | Influenza Antigen B/Shangdong/7/97 Influenza Reagent |
| 98/778 | Influenza Virus infectious A/Sichuan/346/98 (H3N2) Influenza Reagent |
| 99/506 | Anti-PT S1 subunit Monoclonal Antibody (1B7) Non WHO Reference Material |
| 99/508 | Anti-PT S1 subunit Monoclonal Antibody (1D7) Non WHO Reference Material |
| 99/510 | Anti-PT S1 subunit Monoclonal Antibody (3F11) Non WHO Reference Material |
| 99/512 | Anti-PT S1 subunit Monoclonal Antibody (10D6) Non WHO Reference Material |
| 99/514 | Anti-PT S1 subunit Monoclonal Antibody (8G4) Non WHO Reference Material |
| 99/516 | Anti-PT S1 subunit Monoclonal Antibody (E1E) Non WHO Reference Material |
| 99/518 | Anti-PT S1 subunit Monoclonal Antibody (E2E) Non WHO Reference Material |
| 99/520 | Anti-PT S1 subunit Monoclonal Antibody (3F10) Non WHO Reference Material |
| 99/522 | Anti-PT S1 subunit Monoclonal Antibody (11D9) Non WHO Reference Material |
| 99/524 | Anti-PT S1 subunit Monoclonal Antibody (4D10) Non WHO Reference Material |
| 99/526 | Anti-PT S23 subunit Monoclonal Antibody (11E6) Non WHO Reference Material |
| 99/528 | Anti-PT S23 subunit Monoclonal Antibody (10C9) Non WHO Reference Material |
| 99/530 | Anti-PT S23 subunit Monoclonal Antibody (10B5) Non WHO Reference Material |
| 99/532 | Anti-PT S23 subunit Monoclonal Antibody (G9A) Non WHO Reference Material |
| 99/534 | Anti-PT S23 subunit Monoclonal Antibody (3F6) Non WHO Reference Material |
| 99/536 | Anti-PT S2 subunit Monoclonal Antibody (3A12) Non WHO Reference Material |
| 99/538 | Anti-PT S2 subunit Monoclonal Antibody (2H3) Non WHO Reference Material |
| 99/540 | Anti-PT S2 subunit Monoclonal Antibody (9G8) Non WHO Reference Material |
| 99/542 | Anti-PT S3 subunit Monoclonal Antibody (7E10) Non WHO Reference Material |
| 99/544 | Anti-PT S3 subunit Monoclonal Antibody (7G11) Non WHO Reference Material |
| 99/546 | Anti-PT S3 subunit Monoclonal Antibody (4G5) Non WHO Reference Material |
| 99/548 | Anti-PT S3 subunit Monoclonal Antibody (2E12) Non WHO Reference Material |
| 99/550 | Anti-PT S3 subunit Monoclonal Antibody (6F8) Non WHO Reference Material |
| 99/552 | Anti-PT S3 subunit Monoclonal Antibody (10B8) Non WHO Reference Material |
| 99/554 | Anti-PT S4 subunit Monoclonal Antibody (7F2) Non WHO Reference Material |
| 99/556 | Anti-PT S4 subunit Monoclonal Antibody (6B3) Non WHO Reference Material |
| 99/558 | Anti-PT S4 subunit Monoclonal Antibody (6G8) Non WHO Reference Material |
| 99/560 | Anti-PT S4 subunit Monoclonal Antibody (9F3) Non WHO Reference Material |
| 99/562 | Anti-PT S4 subunit Monoclonal Antibody (1H2) Non WHO Reference Material |
| 99/564 | Anti-PT S4 subunit Monoclonal Antibody (9C6) Non WHO Reference Material |
| 99/566 | Anti-PT S4 subunit Monoclonal Antibody (6D6) Non WHO Reference Material |
| 99/568 | Anti-PT S5 subunit Monoclonal Antibody (7E3) Non WHO Reference Material |
| 99/570 | Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6) Non WHO Reference Material |
| 99/572 | Anti-Filamentous Haemagglutinin Monoclonal Antibody (2E9) Non WHO Reference Material |
| 99/574 | Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10) Non WHO Reference Material |
| 99/586 | Influenza Antigen B/Yamanashi/166/98 Influenza Reagent |
| 99/614 | Influenza Antigen A/Sydney/5/97 Influenza Reagent |
| 99/616 | Yellow Fever Vaccine. WHO International Standard WHO International Standard |
| 99/624 | Influenza Antigen A/Sydney/5/97 Influenza Reagent |
| 99/634-007 | HIV-1 RNA Working Reagent 1 (PWS-1) for NAT Assays CE Marked Material |
| 99/636-007 | HIV-1 RNA Working Reagent 2 for NAT assays CE Marked Material |
| 99/642 | Chorionic Gonadotrophin, nicked, human. WHO Reference Reagent WHO International Standard |
| 99/650 | Chorionic Gonadotrophin, beta subunit, human. WHO Reference Reagent WHO International Standard |
| 99/666 | Anti-HPA-5b (Minimum Potency) WHO Reference Reagent WHO International Standard |
| 99/674-016 | HIV-2 (antibody) Monitor Sample CE Marked Material |
| 99/686 | Parvovirus B19 DNA Reference Material for Nucleic Acid Amplification Techniques Non WHO Reference Material |
| 99/688 | Chorionic Gonadatrophin, intact, Human. WHO Reference Reagent WHO International Standard |
| 99/692 | Chorionic Gonadotrophin, nicked beta subunit, Human WHO Reference Reagent WHO International Standard |
| 99/706 | Anti-Meningococcal human reference serum CDC1992 Non WHO Reference Material |
| 99/708 | Chorionic Gonadatrophin, beta core fragment, Human WHO Reference Reagent WHO International Standard |
| 99/710-020 | HIV-1 (antibody) (1 in 5 dilution) British Working Standard CE Marked Material |
| 99/714 | Influenza Antigen A/Singapore/1/57 (H2N2) Influenza Reagent |
| 99/720 | Chorionic Gonadotrophin, alpha subunit, Human (purified) WHO International Standard |
| 99/728 | Anti-D Immunoglobulin Control Working Standard |
| 99/750-022 | HIV-1 (antibody) British Working Standard) CE Marked Material |
| 99/824 | Influenza Virus infectious RESVIR 16 (H3N2) Influenza Reagent |
| 99/828 | Influenza Antigen B/Yamanashi/166/98 Influenza Reagent |
| 99/836 | Anti-D Minimum Potency Standard for blood grouping reagents WHO International Standard WHO International Standard |
| AFP | Alpha-Foetoprotein. WHO International Standard WHO International Standard |
| B2M | Beta-2 Microglobulin. WHO International Standard WHO International Standard |
| BUSB | Botulinum Antitoxin Equine Type B. WHO International Standard WHO International Standard |
| CDS | Anti-Canine Distemper Serum. WHO International Standard WHO International Standard |
| CHAN | Cholera Antitoxin, Goat. WHO International Standard WHO International Standard |
| CHS | Anti-Canine Hepatitis Serum WHO International Standard |
| COT | Clostridium novyi (alpha) Toxoid. WHO Reference Reagent WHO International Standard |
| CWBETATD | Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT WHO Reference Reagent WHO International Standard |
| CWEPSILONTD | Clostridium Welchii (Perfringens)( Epsilon) Toxoid CwDT WHO Reference Reagent WHO International Standard |
| DY | Anti-Dysentery (shiga) serum, Equine. WHO International Standard WHO International Standard |
| JNIH-11 | Bordetella pertussis anti FHA serum (mouse) Non WHO Reference Material |
| JNIH-12 | Bordetella pertussis PT( LPF) anti serum, (mouse) Non WHO Reference Material |
| JNIH-3 | Acellular Pertussis Vaccine - 1st IS. WHO International Standard |
| JNIH-4 | Bordetella pertussis filamentous haemagglutinin (FHA) Non WHO Reference Material |
| JNIH-5 | Bordetella pertussis toxin (PT) 1st IS WHO International Standard |
| MEF/001 | Primary Mouse Embryo Fibroblasts (p0) UK Stem Cell Bank |
| MGDS | Anti-Mycoplasma gallisepticum Serum. WHO Reference Reagent WHO International Standard |
| NDS | Anti-Newcastle Disease Serum. WHO International Standard WHO International Standard |
| NVIA | Newcastle Disease Vaccine (Inactivated) WHO International Standard WHO International Standard |
| OE | Gas Gangrene Antitoxin (Cl. novyi), Equine WHO International Standard WHO International Standard |
| PE | Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine WHO International Standard WHO International Standard |
| PPDA | Purified Protein Derivative (PPD) of M Avium Tuberculin WHO International Standard WHO International Standard |
| PPDBOV | Purified Protein Derivative (PPD) of Bovine Tuberculin WHO International Standard WHO International Standard |
| PPDT | Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin WHO International Standard WHO International Standard |
| QF | Anti-Q Fever Serum, Bovine WHO International Standard WHO International Standard |
| RAI | Anti-rabies Immunoglobulin, Human WHO International Standard WHO International Standard |
| RBT/16 | Thromboplastin, Rabbit, Plain 5th International Standard 2016. WHO International Standard |
| RTF/16 | Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016. WHO International Standard |
| RUBI-1-94 | Anti-rubella Immunoglobulin, Human WHO International Standard WHO International Standard |
| SES | Swine Erysipelas Serum (anti-N) WHO Reference Reagent WHO International Standard |
| SFS | Anti-Swine Fever Serum WHO International Standard WHO International Standard |
| SMV | Smallpox Vaccine WHO International Standard WHO International Standard |
| SPDS-S2 | Anti-Salmonella Pullorum Serum (Std. Form S) WHO International Standard WHO International Standard |
| SPDS-V | Anti-Salmonella Pullorum Serum (Variant Form V) WHO International Standard WHO International Standard |
| SPLS | Anti-Staphylococcal P-V Leucocidin serum, Equine WHO Reference Reagent WHO International Standard |
| SS-319/20 | FITC CD4 Positive Control Cells CE Marked Material |
| SSCLOT4 | SSC/ISTH Secondary Coagulation Standard Lot#4 Non WHO Reference Material |
| STA | Staphylococcus Alpha Antitoxin, Equine WHO International Standard WHO International Standard |
| STT | Diphtheria (Schick) Test Toxin WHO International Standard WHO International Standard |
| TE-3 | Tetanus Immunoglobulin, Human WHO International Standard WHO International Standard |
| TILI | Anti-tick borne encephalitis serum (Louping Ill) WHO International Standard WHO International Standard |
| TISA | Anti-tick borne encephalitis serum (Sophyn & Absettarov) WHO International Standard WHO International Standard |
| TYVK | Typhoid Vaccine (acetone-inactivated) WHO International Standard WHO International Standard |
| TYVL | Typhoid Vaccine (heat-phenol-inactivated) WHO International Standard WHO International Standard |
| VI | Gas Gangrene Antitoxin (Cl. Septicum), Equine WHO International Standard WHO International Standard |
| W1004 | Anti-C complete blood typing serum,human WHO International Standard WHO International Standard |
| W1005 | Anti-E complete blood typing serum, human WHO International Standard WHO International Standard |
| W1007 | Anti-c Incomplete blood typing serum, human WHO International Standard WHO International Standard |
| W1044 | Anti-Varicella zoster immunoglobulin WHO International Standard WHO International Standard |
| W1062 | Anti smooth muscle(anti actin) autoantibody. WHO Reference Reagent WHO International Standard |
| W1063 | Anti nuclear ribonucleoprotein(nRNP) autoantibody WHO Reference Reagent WHO International Standard |
| W1064 | Anti-Nuclear factor serum,homogenous(66/233) Non WHO Reference Material |
| W1066 | Rheumatoid Arthritis serum. WHO Reference Reagent WHO International Standard |
| YF | Anti-Yellow Fever Serum, monkey WHO Reference Reagent WHO International Standard |
关于我们
Wolcavi Biotech致力于干细胞免疫治疗、分子生物学 、免疫学、体外诊断等相关领域的实验需求产品开发和销售。主要产品有抗原抗体|无血清培养基|细胞培养耗材并代理销售Abcam、Invitrogen(Gibco)、Roche、Sigma、R&D、Meridian等二十多家国外知名品牌。
联系我们
- 北京市通州区金桥科技园景盛南二街12号纳特园区
- Phone: +86 010 8646 3560
- Email: info@wolcavi.com
资讯
你将通过这个邮件订阅我们的产品资讯和新闻
© Copyright 2021 by WOLCAVI BIOTECH All Rights Reserved. 京ICP备15043915号-1